B of A Securities Maintains Neutral on Prothena Corp, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
B of A Securities has maintained a Neutral rating on Prothena Corp and lowered its price target from $33 to $31.
October 01, 2024 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
B of A Securities has maintained a Neutral rating on Prothena Corp and lowered its price target from $33 to $31.
The lowering of the price target from $33 to $31 by B of A Securities suggests a slightly negative outlook on Prothena's stock performance. The Neutral rating indicates no strong buy or sell recommendation, but the reduced price target could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100